Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geralyn Annett

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|June 12, 2013
Mesenchymal stem cells for trinucleotide repeat disordersGeralyn Annett, Gerhard Bauer, Jan A Nolta
Seminars in Immunopathology|June 18, 2009
Contribution of human hematopoietic stem cells to liver repairPing Zhou, Louisa Wirthlin, Jeannine McGee, et al.
Regenerative Medicine|November 19, 2010
Mesenchymal stem cells for the treatment of neurodegenerative diseaseNanette Joyce, Geralyn Annett, Louisa Wirthlin, et al.
Neural Regeneration Research|June 24, 2016
Clinical trial perspective for adult and juvenile Huntington's disease using genetically-engineered mesenchymal stem cellsPeter Deng, Audrey Torrest, Kari Pollock, et al.
Expert Opinion on Biological Therapy|May 10, 2016
Engineered BDNF producing cells as a potential treatment for neurologic diseasePeter Deng, Johnathon D Anderson, Abigail S Yu, et al.
Advanced Drug Delivery Reviews|October 6, 2010
Mesenchymal stem cells for the sustained in vivo delivery of bioactive factorsTodd Meyerrose, Scott Olson, Suzanne Pontow, et al.
Regenerative Medicine|August 4, 2015
Developing stem cell therapies for juvenile and adult-onset Huntington's diseaseKyle D Fink, Peter Deng, Audrey Torrest, et al.
Investigative Ophthalmology & Visual Science|August 19, 2016
Intravitreal Administration of Human Bone Marrow CD34+ Stem Cells in a Murine Model of Retinal DegenerationElad Moisseiev, Zeljka Smit-McBride, Sharon Oltjen, et al.
Molecular Therapy. Methods & Clinical Development|September 10, 2016
Preclinical evaluation of mesenchymal stem cells overexpressing VEGF to treat critical limb ischemiaJulie R Beegle, Nataly Lessa Magner, Stefanos Kalomoiris, et al.
Transfusion|November 2, 2018
Mesenchymal stem/stromal cells genetically engineered to produce vascular endothelial growth factor for revascularization in wound healing and ischemic conditionsFernando A Fierro, Nataly Magner, Julie Beegle, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|June 12, 2013
Mesenchymal stem cells for trinucleotide repeat disordersGeralyn Annett, Gerhard Bauer, Jan A Nolta
Seminars in Immunopathology|June 18, 2009
Contribution of human hematopoietic stem cells to liver repairPing Zhou, Louisa Wirthlin, Jeannine McGee, et al.
Regenerative Medicine|November 19, 2010
Mesenchymal stem cells for the treatment of neurodegenerative diseaseNanette Joyce, Geralyn Annett, Louisa Wirthlin, et al.
Neural Regeneration Research|June 24, 2016
Clinical trial perspective for adult and juvenile Huntington's disease using genetically-engineered mesenchymal stem cellsPeter Deng, Audrey Torrest, Kari Pollock, et al.
Expert Opinion on Biological Therapy|May 10, 2016
Engineered BDNF producing cells as a potential treatment for neurologic diseasePeter Deng, Johnathon D Anderson, Abigail S Yu, et al.
Advanced Drug Delivery Reviews|October 6, 2010
Mesenchymal stem cells for the sustained in vivo delivery of bioactive factorsTodd Meyerrose, Scott Olson, Suzanne Pontow, et al.
Regenerative Medicine|August 4, 2015
Developing stem cell therapies for juvenile and adult-onset Huntington's diseaseKyle D Fink, Peter Deng, Audrey Torrest, et al.
Investigative Ophthalmology & Visual Science|August 19, 2016
Intravitreal Administration of Human Bone Marrow CD34+ Stem Cells in a Murine Model of Retinal DegenerationElad Moisseiev, Zeljka Smit-McBride, Sharon Oltjen, et al.
Molecular Therapy. Methods & Clinical Development|September 10, 2016
Preclinical evaluation of mesenchymal stem cells overexpressing VEGF to treat critical limb ischemiaJulie R Beegle, Nataly Lessa Magner, Stefanos Kalomoiris, et al.
Transfusion|November 2, 2018
Mesenchymal stem/stromal cells genetically engineered to produce vascular endothelial growth factor for revascularization in wound healing and ischemic conditionsFernando A Fierro, Nataly Magner, Julie Beegle, et al.
Pageof 2